Creative Planning trimmed its holdings in shares of Neogen Co. (NASDAQ:NEOG) by 32.2% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 5,618 shares of the company’s stock after selling 2,672 shares during the quarter. Creative Planning’s holdings in Neogen were worth $436,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also made changes to their positions in the company. State of Tennessee Treasury Department boosted its position in shares of Neogen by 0.6% in the first quarter. State of Tennessee Treasury Department now owns 28,659 shares of the company’s stock worth $1,920,000 after purchasing an additional 173 shares during the period. Oregon Public Employees Retirement Fund boosted its position in shares of Neogen by 1.0% in the second quarter. Oregon Public Employees Retirement Fund now owns 21,137 shares of the company’s stock worth $1,640,000 after purchasing an additional 200 shares during the period. Quadrant Capital Group LLC boosted its position in shares of Neogen by 17.6% in the fourth quarter. Quadrant Capital Group LLC now owns 1,436 shares of the company’s stock worth $90,000 after purchasing an additional 215 shares during the period. Sunbelt Securities Inc. purchased a new position in shares of Neogen in the fourth quarter worth $4,220,000. Finally, Versant Capital Management Inc lifted its holdings in shares of Neogen by 256.2% in the first quarter. Versant Capital Management Inc now owns 374 shares of the company’s stock worth $25,000 after buying an additional 269 shares in the last quarter. Institutional investors own 92.91% of the company’s stock.

In other news, VP Jason Warren Lilly sold 885 shares of the stock in a transaction on Tuesday, May 5th. The shares were sold at an average price of $64.00, for a total value of $56,640.00. Following the sale, the vice president now owns 10,409 shares of the company’s stock, valued at $666,176. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Corporate insiders own 1.70% of the company’s stock.

NEOG has been the topic of several research analyst reports. Stephens reissued a “buy” rating and issued a $88.00 target price on shares of Neogen in a report on Tuesday, July 14th. William Blair reissued a “market perform” rating on shares of Neogen in a report on Tuesday, July 21st. BidaskClub raised shares of Neogen from a “hold” rating to a “buy” rating in a report on Friday, June 26th. Roth Capital boosted their target price on shares of Neogen from $67.00 to $75.00 and gave the stock a “neutral” rating in a report on Thursday, July 23rd. Finally, TheStreet raised shares of Neogen from a “c” rating to a “b-” rating in a research note on Monday, May 11th. One research analyst has rated the stock with a sell rating, three have issued a hold rating and two have issued a buy rating to the stock. The company has an average rating of “Hold” and a consensus target price of $75.67.

Neogen stock opened at $76.77 on Friday. The company has a market cap of $3.97 billion, a price-to-earnings ratio of 67.94, a PEG ratio of 6.18 and a beta of 0.75. The firm’s fifty day moving average is $75.03 and its 200 day moving average is $68.27. Neogen Co. has a 52-week low of $48.91 and a 52-week high of $80.84.

Neogen (NASDAQ:NEOG) last released its quarterly earnings results on Tuesday, July 21st. The company reported $0.31 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.30 by $0.01. The company had revenue of $109.10 million for the quarter, compared to the consensus estimate of $112.15 million. Neogen had a net margin of 14.22% and a return on equity of 8.53%. Neogen’s revenue was down .8% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.30 earnings per share. As a group, sell-side analysts anticipate that Neogen Co. will post 1.22 EPS for the current year.

Neogen Company Profile

Neogen Corporation, together with its subsidiaries, develops, manufactures, and markets various products for food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment primarily offers diagnostic test kits and complementary to detect dangerous and/or unintended substances in human food and animal feed, such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test for adenosine triphosphate, a chemical found in living cells.

Featured Story: How Do Front-End Loads Impact an Investment?

Want to see what other hedge funds are holding NEOG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Neogen Co. (NASDAQ:NEOG).

Institutional Ownership by Quarter for Neogen (NASDAQ:NEOG)

Receive News & Ratings for Neogen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neogen and related companies with MarketBeat.com's FREE daily email newsletter.